Cargando…

Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs

Detalles Bibliográficos
Autores principales:	Sisa, Ivan, Noblecilla, Estefania, Orozco, Fadya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906642/ https://www.ncbi.nlm.nih.gov/pubmed/33617776 http://dx.doi.org/10.1016/S0140-6736(21)00357-3

Ejemplares similares

COVID-19 research in LMICs
por: Sisa, Ivan, et al.
Publicado: (2021)

COVID-19: an opportunity to improve infection prevention and control in LMICs
por: Maina, Michuki, et al.
Publicado: (2020)

GeneXpert for the diagnosis of COVID-19 in LMICs
por: Rakotosamimanana, Niaina, et al.
Publicado: (2020)

COVID-19 research in LMICs – Authors' reply
por: Torres, Irene, et al.
Publicado: (2021)

Vaccine scarcity in LMICs is a failure of global solidarity and multilateral instruments
por: Torres, Irene, et al.
Publicado: (2021)

Challenges of globalization of cancer drug trials- recruitment in LMICs, approval in HICs
por: Gyawali, Bishal, et al.
Publicado: (2021)

Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2021)

Vaccine approval before phase 3 trial results: a consequence of vaccine access inequity
por: Núñez, Isaac
Publicado: (2022)

Conducting placebo controlled randomized trials
por: Raina, Sunil Kumar
Publicado: (2015)

A real challenge to tackle the overuse of antibiotics in LMIC: A case from Vietnam
por: Bui, Dinh Son, et al.
Publicado: (2022)

Do the Approved Societies Seek to Control the Doctors?
por: Ward, Gordon
Publicado: (1922)

Contemporary oncology trials, drug approvals and the physician-patient relationship
por: Schnog, John-John B., et al.
Publicado: (2022)

The need for COVID-19 clinical trials in LMICs
por: Saleh, Fatima
Publicado: (2023)

Hospitals and Approved Societies
por: Dunstan, S.
Publicado: (1923)

Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
por: Kaur, Hardeep, et al.
Publicado: (2021)

Approved Societies and Hospital Treatment
por: Squires, F.
Publicado: (1922)

Approved Societies and Hospital Treatment
por: Squires, F.
Publicado: (1922)

Approved Societies and Hospital Treatment
por: Michelli, P. J.
Publicado: (1922)

COVID-19 vaccines for children in LMICs: another equity issue
por: Kampmann, Beate, et al.
Publicado: (2021)

Edinburgh Royal Infirmary and Approved Societies
por: Caw, Wm. S.
Publicado: (1922)

Section 12 approval: fit for purpose?
por: Gupta, Nidhi, et al.
Publicado: (2020)

Section 12 approval: fit for purpose?
por: Ballantyne-Watts, Darryl
Publicado: (2020)

Research approvals iceberg: helping it melt away
por: Kolstoe, Simon E., et al.
Publicado: (2019)

Time from US Food and Drug Administration approval to publication of data for cancer drugs: a comparison of first and subsequent approvals
por: Lammers, Austin, et al.
Publicado: (2017)

Rationale of anticoagulation among patients of COVID-19 undergoing cardiac surgery
por: Sharma, Dhruva
Publicado: (2020)

The Debate over Placebo-Controlled Trials
por: Miller, Frankllin
Publicado: (2005)

Section 12(2) MHA approval process is fit for purpose
por: Khwaja, Masum
Publicado: (2020)

Rationale of receptor-based antivirals against SARS
Publicado: (2013)

COVID-19 in pregnancy: evidence from LMICs
por: Costa, Maria Laura, et al.
Publicado: (2022)

The Rationale of Malaria Treatment in Syphilis of the Central Nervous System
por: Brooks, A. G.
Publicado: (1928)

Rationale for a new registry on EVAR: The EXTREME study
por: Sirignano, Pasqualino, et al.
Publicado: (2017)

Portal Vein Thrombosis in Decompensated Cirrhosis: Rationale for Treatment
por: Senzolo, Marco, et al.
Publicado: (2019)

Sex-disaggregated data in COVID-19 vaccine trials
por: Vijayasingham, Lavanya, et al.
Publicado: (2021)

Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults
por: Lambert, David, et al.
Publicado: (2020)

I-ACT for Children: helping close the gap in drug approval for adults and children
por: Coppes, Max J., et al.
Publicado: (2022)

Even more suicide attempts in clinical trials with paroxetine randomised against placebo
por: Aursnes, Ivar, et al.
Publicado: (2006)

Revalidation and rationale for high pKa values of unconjugated bilirubin
por: Ostrow, J Donald, et al.
Publicado: (2007)

A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis
por: Liu, Mingsheng, et al.
Publicado: (2023)

Trial participants' rights after authorisation of COVID-19 vaccines
por: Dal-Ré, Rafael, et al.
Publicado: (2021)

Importance of next-generation diagnostics in control of tuberculosis in LMICs
por: Hasan, Zahra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_75miaaa42g0bupor1qe0b1idn7